Sangamo Therapeutics, Inc
SGMOQOTCCIK 1001233HealthcareFiscal year ends Dec 31
Reports and events: 298 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1617:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-423054 |
| 2026-09-2116:01 ET | 8-K | 1.03 Bankruptcy or receivership; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-396644 |
| 2026-09-0816:06 ET | 8-K | 1.03 Bankruptcy or receivership; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-105905 |
| 2026-08-2816:05 ET | 8-K | 1.01 Entry into a material agreement; 1.03 Bankruptcy or receivership; 9.01 Financial statements and exhibits | 0001193125-26-374328 |
| 2026-08-1321:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347524 |
| 2026-08-1216:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-346796 |
| 2026-07-2016:44 ET | 8-K | 1.03 Bankruptcy or receivership; 3.01 Delisting notice | 0001193125-26-309012 |
| 2026-07-0116:01 ET | 8-K | 4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-292501 |
| 2026-06-2316:42 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-26-279630 |
| 2026-06-2308:45 ET | 8-K | 1.01 Entry into a material agreement; 1.03 Bankruptcy or receivership; 2.03 New direct financial obligation; 2.05 Exit or disposal costs | 0001193125-26-278582 |
| 2026-05-1416:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-035067 |
| 2026-05-1416:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-035061 |
| 2026-04-3019:34 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001628280-26-028524 |
| 2026-04-2908:37 ET | 8-K | 3.01 Delisting notice | 0001628280-26-028128 |
| 2026-03-3017:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-022029 |
| 2026-03-3017:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-022006 |
| 2026-02-0408:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-036792 |
| 2026-02-0316:07 ET | 8-K | 8.01 Other events | 0001001233-26-000005 |
| 2026-02-0308:55 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001001233-26-000002 |
| 2025-11-0608:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001001233-25-000024 |
| 2025-11-0608:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001001233-25-000023 |
| 2025-10-2916:08 ET | 8-K | 3.01 Delisting notice | 0001001233-25-000015 |
| 2025-09-3016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001001233-25-000013 |
| 2025-09-1117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001001233-25-000011 |
| 2025-09-0408:06 ET | 8-K | 8.01 Other events | 0001001233-25-000006 |
| 2025-08-0716:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038860 |
| 2025-08-0716:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038855 |
| 2025-06-2408:08 ET | 8-K | 8.01 Other events | 0001628280-25-032748 |
| 2025-06-1616:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-031559 |
| 2025-05-1317:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-018697 |
| 2025-05-1216:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-024650 |
| 2025-05-0616:03 ET | 8-K | 3.01 Delisting notice | 0001628280-25-022664 |
| 2025-04-3017:35 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001628280-25-020773 |
| 2025-03-1716:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-013088 |
| 2025-03-1716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-013085 |
| 2025-02-0608:13 ET | 8-K | 8.01 Other events | 0001628280-25-004197 |
| 2024-12-3016:23 ET | 8-K | 1.02 Termination of a material agreement | 0001628280-24-052579 |
| 2024-12-1021:27 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-050545 |
| 2024-11-1216:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-047102 |
| 2024-11-1216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-047099 |
| 2024-10-0416:03 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-24-042308 |
| 2024-08-0616:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035165 |
| 2024-08-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035160 |
| 2024-07-2416:05 ET | 8-K | 8.01 Other events | 0001628280-24-032815 |
| 2024-06-0517:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-026903 |
| 2024-05-0916:04 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-022194 |
| 2024-05-0916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-022186 |
| 2024-04-3016:02 ET | 8-K | 3.01 Delisting notice | 0001628280-24-019337 |
| 2024-04-1916:01 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001628280-24-016932 |
| 2024-03-2517:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-076613 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:02 ET. Listed shows no prices and gives no investment advice.